Canadian-listed, German-based bioscience accelerator BioNxt (BNXT.C) has announced it plans to give warrant holders an additional year to exercise 2022-purchased $0.50 warrants of the company, as its stock steadily…
drug delivery
Biotech companies are notoriously difficult to find investor love for in Canada, at least historically, so it’s no surprise that BioNxt Solutions (BNXT.C) is headquartered in Germany. That proximity…
Today I found myself going down an investment rabbit hole, chasing information about a company that, to be honest, is wallowing, and has for a while. Unmarketed. Unexplained. Unsimple….
People really don’t like pharma companies in Canada. We’ve had some monster megacorporations come out of Canada in the pharma space, and the biotech space, and a lot of…
Bionxt Solutions Inc. (BNXT.C) has finished a study on a new type of medicine strip that dissolves in your mouth. This strip is designed to treat multiple sclerosis (MS),…
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was…
InnoCan Pharma Corporation, trading on the Canadian Securities Exchange under the symbol INNO, FSE: IP4, and OTC: INNPF, is a pharmaceutical technology company that has garnered attention in the…
Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the…
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged…
Hey y’all, Lucy Copperpot back for more analysis of Equity.Guru companies – this one is no longer on the client list, but I asked for permission to dig in…